GBS International Student Webinar GBSO organizes a webinar hosted by current GBS students, International Student and Scholar Services representative, and GBS office representative to address questions ...

Annexon Biosciences CEO Doug Love considers Guillain-Barré syndrome — also known as GBS — to be the “most unique disease” he’s worked on in 25 years in biotech because of its sudden onset. A rare ...

With GBS’ deep expertise in cybersecurity, cloud solutions, and managed IT services, combined with Binary Consulting Services’ experience in ERP, CRM, and robotic process automation (RPA), this ...

Entain has enhanced the customer experience across its UK and Irish Ladbrokes and Coral shops with the rollout of Group ...

According to the National Institutes Of Health, "Guillain-Barré syndrome (GBS) is a rare but serious post-infectious immune-mediated neuropathy. It results from the autoimmune destruction of ...

This season, HighRadius founder and CEO Sashi Narahari will talk with leading GBS executives from some of the world’s top companies about the business model’s future. Building on the theme of ...

GBS said that this “regulatory anomaly” could be cured if that broadcaster could use a distributed transmission system focused on a full-service “reference coordinates” established by the broadcaster.

Participating together at the IDC Saudi Arabia CIO Summit on 18-19th September 2024, GBS and SymphonyAI demonstrated a cutting-edge AI-powered IT Services Management (ITSM) platform to refine and ...

Multiple sclerosis (MS) and Guillain-Barré syndrome (GBS) are diseases of the nervous system. They’re not the same, but they do have a lot of similarities. Both MS and GBS are autoimmune ...

Guillain-Barré syndrome (GBS) is a rare autoimmune disorder where the immune system attacks the peripheral nervous system, affecting muscle control and sensory signals.